ZBH

As of 2026-09-11, ZBH scores 52out of 100 on QNTM’s five-factor quantitative model, a moderate conviction reading. The score blends momentum, quality, volume, value and sentiment, then adjusts for the current macro regime. ZBH trades at $93.49, 26% below the band floor.

ZBH scores 52 out of 100 on QNTM's five-factor model — a moderate reading — neither strongly favored nor flagged for weakness at 52. Its strongest factor is value at 89 (exceptional), where it screens cheap on the model's valuation inputs, followed by sentiment at 50. The weakest is momentum at 40, where price trend is the soft spot. Among Healthcare stocks it ranks in roughly the top 27% of the Healthcare names the model scores.

On valuation, ZBH is priced near the floor of its own recent range — the cheap end on the model's valuation read. The profile is lopsided — a few factors carry it while others drag, so the composite masks real disagreement underneath. The blended composite before the macro overlay was 53. Same-sector names the model rates nearby include HALO, THC, HNGE.

This is a descriptive factor read on ZBH, recomputed each trading day and shown with its reasoning — not a recommendation to buy, hold or sell. The score reflects where ZBH sits on the model's measures today, and can change as new data arrives.

FACTOR BREAKDOWN

VALUATION RANGE

QNTM’s descriptive fair-value band for ZBH runs $126.29–$175.11. Current price $93.49 sits 26% below the band floor. This is valuation context, not a price target.

OTHER HEALTHCARE NAMES

QNTM provides quantitative model outputs for informational and educational purposes only. It is not investment advice and QNTM is not a registered investment adviser. Scores are rankings, not buy/sell recommendations. Data as of 2026-09-11.